Receivable Sales Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ashland reports financial results1 for fourth-quarter fiscal 2023; issues outlook for first-quarter fiscal 2024

Sales of $518 million, down eighteen percent from the prior-year quarterNet loss of $4 million, or $0.07 per diluted shareLoss from continuing operations of $8 million, or $0.15 per diluted.

Setha mrozekGuillermo novoCarolmariec brownLife sciencesAshland incSecurities exchangeExchange commissionUs accounts receivable sales programPerformance adhesivesInnovation dayInvestor relationsSecurities actSecurities exchange actRisk factorsReceivable sales program

Ashland reports financial results1 for third quarter of fiscal year 2023

Ashland reports financial results1 for third quarter of fiscal year 2023
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesCarolmariec brownSetha mrozekGuillermo novoExchange commissionLife sciencesSecurities exchangeUs accounts receivable sales programAshland incInnovation daySecurities actSecurities exchange actRisk factorsReceivable sales program

Ashland reports financial results1 for third quarter of

Sales of $546 million, down 15 percent compared to the prior-year quarterNet income (including discontinued operations) of $50 million, or $0.94 per.

United statesGuillermo novoCarolmariec brownSetha mrozekLife sciencesAshland incUs accounts receivable sales programSecurities exchangeExchange commissionInnovation daySecurities actSecurities exchange actRisk factorsReceivable sales programNyse ash

Ashland reports financial results1 for third quarter of fiscal year 2023

Ashland reports financial results1 for third quarter of fiscal year 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSetha mrozekCarolmariec brownGuillermo novoLife sciencesSecurities exchangeUs accounts receivable sales programAshland incExchange commissionInnovation daySecurities actSecurities exchange actRisk factorsReceivable sales program

Ashland reports financial results1 for second quarter of

Sales of $603 million consistent with the prior-year quarterNet income (including discontinued operations) of $91 million, or $1.67 per diluted.

Carolmariec brownGuillermo novoSetha mrozekExchange commissionUs accounts receivable sales programAshland incLife sciencesSecurities exchangePersonal careCalvert citySpecialty additivesSecurities actSecurities exchange actRisk factorsReceivable sales programNyse ash